Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EPS (Weighted Average and Diluted) (2021 - 2025)

Biote has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at $0.22 for Q3 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $0.22 for Q3 2025, down 33.33% from a year ago — trailing twelve months through Sep 2025 was $0.8 (up 150.0% YoY), and the annual figure for FY2024 was $0.09, down 30.77%.
  • EPS (Weighted Average and Diluted) for Q3 2025 was $0.22 at Biote, up from $0.1 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for BTMD hit a ceiling of $0.68 in Q4 2021 and a floor of -$0.39 in Q1 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.16 (2025), compared with a mean of $0.09.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 67.65% in 2022 and later surged 408.33% in 2025.
  • Biote's EPS (Weighted Average and Diluted) stood at $0.68 in 2021, then crashed by 67.65% to $0.22 in 2022, then soared by 45.45% to $0.32 in 2023, then plummeted by 65.62% to $0.11 in 2024, then skyrocketed by 100.0% to $0.22 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.22 (Q3 2025), $0.1 (Q2 2025), and $0.37 (Q1 2025) per Business Quant data.